Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Central Nervous Insulin Sensitivity and Insulin Secretion
NCT02870361Completed
- Sponsor
- University Hospital Tübingen
- Start
- Aug 2016
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of regular human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Insulin secretion assessed as serum C-peptide levels. Started Aug 2016; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02870361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02870361.